Rise
in the world’s aging population, increase in the number of patients
living with Parkinson’s disease and growing awareness about
neurological movement disorders among patients have triggered the
growth of Deep Brain Stimulation devices market. Globally,
neurological disorders are the main causes of mortality; these
account for approximately 12% of total number of deaths. Of these,
cerebrovascular diseases are responsible for 85% of deaths.
Parkinson’s disease is the most common neurodegenerative movement
disorder after Alzheimer’s.
Browse
Deep Brain Stimulation Market Research Reports with complete TOC at
Drug
therapy is the most effective treatment option available to control
Parkinson’s disease in the initial stages; however, a large number
of medicines are required to control the disease during the advanced
stages. In late stage of the disease, Deep Brain Stimulation (DBS)
surgical treatment is used to control the involuntary symptoms. DBS
is an effective, clinically proven and the U.S. FDA approved advanced
surgical option to treat mild to severe Parkinson’s disease. The
market for DBS devices is expected to grow at a healthy rate during
the forecast period of 2013 to 2019. However, high cost involvement
in the surgical procedure may hamper the growth of the market. A
growing burden of Parkinson’s disease on the healthcare system
coupled with uncertain economic conditions in the U.S. and Europe has
forced Original Equipment Manufacturers (OEMs) to develop
cost-effective devices for the treatment of neurological movement
disorders.
Get
Free Sample Report at
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
The
research report on DBS devices that are used to treat Parkinson’s
disease provides a detailed analysis of the global market and helps
in understanding the various driving forces responsible for the
growth of the market. The report discusses the DBS devices market for
Parkinson’s disease based on prevalence of the disease in four
regions: North America, Europe, Asia Pacific and Latin America. The
market overview section of this report analyzes the market dynamics
and trends such as drivers, restraints and opportunities that
influence the current nature and future status of this market. The
executive summary provides detailed insights about the report and the
market in general. It also provides a market snapshot, which provides
a glimpse into the present scenario of the DBS devices market.
Impact factors such as market attractiveness analysis and Porter’s
five forces analysis have also been explained in the market overview
section of the report in order to deliver a thorough analysis of the
overall competitive scenario of the global DBS devices market.
The
global DBS devices market for Parkinson’s disease has been
segmented with respect to geography. Market size estimates and
forecasts for the period of 2011 to 2019 have been provided for each
of the geography in terms of USD billion, considering 2012 as the
base year for calculations and 2011 as the historical year. The CAGR
(%) of each market segment for the forecast period 2013 to 2019 has
also been provided along with market size estimations.
Browse
Medical Devices Related Research Report at
http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
This
is followed by the market recommendations for the DBS devices market,
these include factors that may play a critical role in enhancing or
boosting the market in the near future, as well as the steps that
need to be taken to ensure success for manufacturers in the near
future.
The
report concludes with the competitive landscape and company profiles
of major market players. These market players have been profiled
based on various attributes such as company overview, financial
overview, business strategies, product portfolio and recent
developments. Prominent players in the market that are profiled in
the report include Medtronic, Inc., St. Jude Medical, Inc. and Boston
Scientific Corporation. Other players that are covered in the report
are Sapiens Neuro and Aleva Neurotherapeutics SA.
Browse Blog http://tmrresearch.wordpress.com/
No comments:
Post a Comment